IMUX
Immunic Inc
NASDAQ: IMUX · HEALTHCARE · BIOTECHNOLOGY
$10.03
-6.70% today
Updated 2026-04-29
Market cap
$135.94M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.20
Dividend yield
—
52W range
$5 – $15
Volume
2.8M
WallStSmart proprietary scores
19
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$53.57
+434.10%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy9 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-19.29M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-120.41M | $-93.61M | $-100.51M | $-97.17M | $-19.30M |
| EPS | — | — | — | — | $-6.20 |
| Free cash flow | $-65.26M | $-71.16M | $-85.03M | $-85.97M | $-19.29M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Immunic Inc trades at $10.03. Our Smart Value Score of 19/100 indicates the stock is weak.
Frequently asked questions
What is Immunic Inc's stock price?
Immunic Inc (IMUX) trades at $10.03.
Is Immunic Inc overvalued?
Smart Value Score 19/100 (Grade F, Strong Sell).
What is the price target of Immunic Inc (IMUX)?
The analyst target price is $53.57, representing +434.1% upside from the current price of $10.03.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-1,653.00%
Beta1.37
50D MA$11.01
200D MA$8.55
Shares out0.01B
Float0.01B
Short ratio—
Avg volume2.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—